Emmanuelle Samalin Selected Research

Emmanuelle Samalin Research Topics

Disease

13	Neoplasms (Cancer) 04/2024 - 07/2007
12	Adenocarcinoma 01/2022 - 07/2007
11	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 09/2009
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024 - 08/2017
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2014
5	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2016
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 03/2012
3	Carcinoma (Carcinomatosis) 07/2023 - 03/2012
3	Disease Progression 01/2022 - 08/2017
2	Microsatellite Instability 12/2023 - 10/2022
2	Frailty 01/2022 - 01/2022
2	Esophageal Neoplasms (Esophageal Cancer) 06/2016 - 07/2007
1	Acute Kidney Injury (Acute Renal Failure) 04/2024
1	Sarcoidosis (Schaumann Disease) 04/2024
1	Anus Neoplasms (Anal Cancer) 04/2024
1	Colitis 04/2024
1	Infections 04/2024
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Circulating Neoplastic Cells 10/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Rare Diseases (Rare Disease) 04/2020
1	Peritoneal Neoplasms 12/2016
1	Peritoneal Diseases 12/2016
1	Diarrhea 12/2016
1	Vitelliform Macular Dystrophy 12/2016
1	Esophageal Squamous Cell Carcinoma 01/2016
1	Posterior Leukoencephalopathy Syndrome 09/2009
1	Hypertension (High Blood Pressure) 09/2009

Drug/Important Bio-Agent (IBA)

16	Fluorouracil (Carac)FDA LinkGeneric 04/2024 - 01/2011
11	Docetaxel (Taxotere)FDA Link 04/2024 - 04/2014
11	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 09/2009
10	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 04/2015
7	Leucovorin (Folinic Acid)FDA Link 11/2022 - 01/2011
6	Cetuximab (Erbitux)FDA Link 01/2024 - 12/2010
6	Irinotecan (Camptosar)FDA LinkGeneric 11/2022 - 09/2009
3	Trastuzumab (Herceptin)FDA Link 01/2021 - 04/2015
3	Gemcitabine FDA Link 01/2021 - 03/2012
3	PlatinumIBA 01/2019 - 01/2018
2	atezolizumabIBA 04/2024 - 04/2020
2	pembrolizumabIBA 04/2024 - 10/2022
2	encorafenibIBA 11/2022 - 11/2020
2	Bevacizumab (Avastin)FDA Link 09/2020 - 09/2009
2	SaltsIBA 04/2018 - 01/2018
2	folfirinoxIBA 04/2013 - 01/2011
1	NivolumabIBA 04/2024
1	Programmed Cell Death 1 ReceptorIBA 04/2024
1	LigandsIBA 04/2024
1	avelumabIBA 04/2024
1	ClaudinsIBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 12/2023
1	Carboplatin (JM8)FDA LinkGeneric 07/2023
1	acifluorfen (Blazer)IBA 11/2022
1	Immune Checkpoint InhibitorsIBA 10/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Everolimus FDA Link 01/2022
1	RamucirumabIBA 01/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022
1	Sunitinib (Sutent)FDA Link 01/2022
1	Epithelial Cell Adhesion MoleculeIBA 10/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	CrizotinibIBA 01/2021
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 12/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	olaparibIBA 09/2019
1	Circulating Tumor DNAIBA 04/2019
1	Panitumumab (Vectibix)FDA Link 01/2019
1	rilotumumabIBA 01/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	EpitopesIBA 01/2018
1	Therapeutic UsesIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Epirubicin (Ellence)FDA LinkGeneric 12/2016
1	AlbuminsIBA 01/2016
1	AntigensIBA 03/2012
1	CarbohydratesIBA 03/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2009

Therapy/Procedure

25	Drug Therapy (Chemotherapy) 04/2024 - 07/2007
5	Therapeutics 01/2022 - 03/2012
2	Proctectomy 02/2024 - 03/2022
2	Radiotherapy 12/2022 - 01/2020
2	Neoadjuvant Therapy 06/2016 - 07/2007
1	Precision Medicine 02/2024
1	Combined Modality Therapy 12/2023
1	TP protocol 07/2023
1	Hepatectomy 11/2022
1	Immunotherapy 10/2022
1	Adjuvant Chemotherapy 01/2021
1	Operative Time 09/2020
1	Folfox protocol 12/2016
1	Laparotomy 12/2016
1	Catheters 12/2016